Sequencing the Underdogs

Transcriptome studies reveal new insights about unusual animals whose genomes have not been sequenced.

Written byEd Yong
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Red spotted newtWIKIMEDIA, JASON QUINNThe red spotted newt (Notophthalmus viridescens) could sit in the palm of your hand, but its genome is ten times the size of yours—up to 10 billion base pairs. This daunting amount of DNA has kept this species off the radar of any genome sequencing projects, despite plummeting costs. It has also prevented newts and salamanders from becoming regular model organisms, despite their remarkable and medically-relevant ability to regenerate severed limbs and damaged organs.

Recently, a team of German scientists circumvented the difficulties posed by the newt’s huge genome by sequencing its transcriptome instead—the set of RNA produced from its genes. Since some of an animal’s genome is never transcribed, transcriptomes can often be decoded at a fraction of the cost and effort of a full genome, and the newt results, published last month (February 20) in Genome Biology, are part of a growing trend of using transcriptomes to understand lesser-known species.

The team, co-led by Thilo Borchardt from the Max-Planck-Institute for Heart and Lung Research, sequenced more than 120,000 RNA transcripts from newt embryos and larvae, at least 14,000 of which code for proteins, and found that many proteins associated with regeneration are not found in other animals, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies